Our Mission

Vision

Decoding Viral Metabolism from Infection to Recovery

The Institute for Viral Metabolism and Therapeutics (IVMT) represents a new paradigm in antiviral research—one that recognizes the critical role of metabolic processes in viral infection, pathogenesis, and recovery.

Our mission is to understand how viruses hijack host cell metabolism, identify metabolic vulnerabilities as therapeutic targets, and develop next-generation treatments that address both acute infection and long-term post-viral syndromes.

By combining world-class experimental virology with cutting-edge computational drug discovery, we aim to transform the landscape of antiviral therapeutics and improve outcomes for patients suffering from viral diseases and their lasting effects.

Strategic Priorities

Our focus areas guide all research and operational decisions

Fundamental Discovery

Elucidate the metabolic mechanisms underlying viral infection, replication, and host cell dysfunction through rigorous basic research.

Computational Innovation

Leverage artificial intelligence and systems biology to accelerate drug discovery and optimize therapeutic candidates.

Clinical Translation

Bridge the gap between laboratory discoveries and patient care through strategic clinical partnerships and trials.

Why Metabolism?

The Metabolic Foundation of Viral Disease

Viruses cannot replicate on their own—they depend entirely on host cell machinery and resources. This dependency creates a fundamental vulnerability that we can exploit therapeutically.

By understanding exactly how viruses reprogram cellular metabolism to support their replication, we can identify targets for intervention that may be more resistant to viral mutation and escape than traditional approaches.

Furthermore, post-viral syndromes like Long COVID and ME/CFS increasingly appear to involve persistent metabolic dysfunction, making our metabolic focus uniquely positioned to address these challenging conditions.

Join Our Mission

We're seeking talented researchers, clinicians, and partners to help advance our vision of transforming viral therapeutics.

View Opportunities Collaborate With Us